Ricovir
Ricovir contains Tenofovir Disoproxil Fumarate, a nucleotide reverse transcriptase inhibitor (NRTI). It is used to manage HIV-1 and chronic Hepatitis B infections by interfering with the viral enzymes needed for replication, thereby reducing the viral load in the body.
Dosage by Body Weight
The standard dose for adults and pediatric patients weighing 35 kg or more is 300 mg taken orally once daily, with or without food. For patients with renal impairment, dosage intervals must be adjusted under strict medical supervision. Pediatric dosing for children weighing less than 35 kg must be determined by a specialist using appropriate pediatric formulations.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established for this weight range.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established for this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- Once daily if prescribed
- Tracking Notes
- Only under specialist supervision using pediatric oral powder formulations if approved.
- Body Weight
- 11-15 kg
- Dose
- 8 mg/kg (using oral powder) or approx. 100 mg - 150 mg
- Frequency
- Once daily
- Tracking Notes
- Must use appropriate pediatric formulation (powder or low-strength tablets). Standard 300 mg tablets are not suitable.
- Body Weight
- 16-20 kg
- Dose
- 150 mg to 200 mg
- Frequency
- Once daily
- Tracking Notes
- Requires low-strength pediatric tablet formulations. Strict monitoring of renal function is advised.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established for this weight range. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established for this weight range. |
| 8-10 kg | Not routine | Once daily if prescribed | Only under specialist supervision using pediatric oral powder formulations if approved. |
| 11-15 kg | 8 mg/kg (using oral powder) or approx. 100 mg - 150 mg | Once daily | Must use appropriate pediatric formulation (powder or low-strength tablets). Standard 300 mg tablets are not suitable. |
| 16-20 kg | 150 mg to 200 mg | Once daily | Requires low-strength pediatric tablet formulations. Strict monitoring of renal function is advised. |
Formulation
Purpose
Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in combination with other antiretroviral agents, and treatment of chronic Hepatitis B virus (HBV) infection.
Generic Name
Tenofovir Disoproxil FumarateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.